HCIL
Hongchang International Co., Ltd
Key Financials
Revenue
$2.9M
↑ 7.1%
Net Income
$-378794
↓ 42.6%
Operating Income
$-383326
↑ 18.4%
EPS (Diluted)
$0.00
NaN%
Total Liabilities
$18.7M
↑ 92.0%
Gross Profit
$181632
↑ 161.9%
Cash & Equivalents
$895730.00
↑ 7738.0%
Shareholders' Equity
$38.8M
↓ 4.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 2/13/2026 | View on SEC |
| 144 | 1/22/2026 | View on SEC |
| 10-Q | 11/13/2025 | View on SEC |
| 10-Q | 8/14/2025 | View on SEC |
| 10-KT | 8/11/2025 | View on SEC |
| 8-K | 5/13/2025 | View on SEC |
| 8-K | 4/30/2025 | View on SEC |
| 10-K | 3/28/2025 | View on SEC |
| 10-Q | 11/13/2024 | View on SEC |
| 8-K/A | 8/28/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HCIL |
| Company Name | Hongchang International Co., Ltd |
| CIK | 1086303 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | NV |
| Phone | 86 180 5901 6050 |